Novel transplant approach improves the odds for leukemia patients

A team lead by Fred Hutch physician-scientist Dr. Marie Bleakley has shown it can dramatically reduce chronic GVHD, a common debilitating side effect of stem cell transplantation in leukemia patients, using magnets to remove “naïve T cells” from the mixture of blood cells from a donor that are to be transplanted into the patient.

Related Keywords

Warren Shlomchik ,Marie Bleakley ,Leukemia Research At Fred Hutch ,University Of Pittsburgh School Medicine ,Fred Hutchinson Cancer Research Center ,Gerdin Family Endowed ,Leukemia Research ,Pittsburgh School ,Hematopoietic Transplantation ,Acute Myeloid Leukemia ,Peripheral Blood Stem Cells ,Allogeneic Transplant ,Lymphodepletion ,Hematopoietic Stem Cell Transplant ,Cell And Gene Therapy ,Survivorship ,T Cell ,